anti-interleukin 1 beta monoclonal antibody FL-101

{
  "id": "MLC-T-ONC-010829",
  "term": "anti-interleukin 1 beta monoclonal antibody FL-101",
  "field": "Oncology and biomedicine",
  "definition": "A monoclonal antibody targeting the human proinflammatory cytokine interleukin-1 beta (IL-1b), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration, anti-IL-1b monoclonal antibody FL-101 targets and binds to IL-1b and prevents the binding of IL-1b to the IL-1 receptor. This inhibits IL-1b-mediated signaling pathways, and suppresses inflammatory responses, tumorigenesis and angiogenesis mediated by IL-1b. IL-1b plays a key role in inflammation, which is present in various disease states including cancers. IL-1b-mediated signaling pathways include MAPK, cyclooxygenase and nuclear factor kappa B (NF-kB) pathways, which may lead to macrophage activation, intra-tumoral accumulation of immunosuppressive myeloid cells, and tumor growth, invasiveness, metastasis, and angiogenesis.",
  "synonyms": [
    "anti-IL-1 beta monoclonal antibody FL-101",
    "anti-interleukin-1beta monoclonal antibody FL-101",
    "anti-IL-1b monoclonal antibody FL-101"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-interleukin-1-beta-monoclonal-antibody-fl-101/"
}